REMEGEN, LTD

Organization

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Bifunctional angiogenesis inhibitor and use thereof
- Patent number 11,629,180
- Issue date Apr 18, 2023
- Remegen Co., Ltd.
- Jing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-...
- Publication number 20240207424
- Publication date Jun 27, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH IMMUNE CHECKPOIN...
- Publication number 20240207431
- Publication date Jun 27, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR DETECTING TCEP CONTENT IN ADC BY LC-MS/MS
- Publication number 20240201147
- Publication date Jun 20, 2024
- RemeGen Co., Ltd.
- Xuejing YAO
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
PHARMACEUTICAL COMBINATION AND USE THEREOF
- Publication number 20240189341
- Publication date Jun 13, 2024
- RemeGen Co., Ltd.
- Xinling ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR DETECTING DTPA CONTENT IN ADC BY LC-MS/MS
- Publication number 20240183827
- Publication date Jun 6, 2024
- REMEGEN CO., LTD
- Xuejing YAO
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF
- Publication number 20240165253
- Publication date May 23, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECI...
- Publication number 20240148894
- Publication date May 9, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREPARATION AND PURIFICATION METHOD OF ANTIBODY DRUG CONJUGATE INTE...
- Publication number 20240033368
- Publication date Feb 1, 2024
- REMEGEN CO., LTD.
- Zhuanglin LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREPARATION AND PURIFICATION PROCESS OF MONOMETHYL AURISTAIN E COMP...
- Publication number 20240025947
- Publication date Jan 25, 2024
- RemeGen Co., Ltd.
- Zhuanglin LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING SJOGREN'S SYNDROME USING TACI-FC FUSION PROTEIN
- Publication number 20240018212
- Publication date Jan 18, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN
- Publication number 20240002468
- Publication date Jan 4, 2024
- REMEGEN CO., LTD.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF
- Publication number 20230272109
- Publication date Aug 31, 2023
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF
- Publication number 20220204626
- Publication date Jun 30, 2022
- REMEGEN CO., LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI PD-L1 ANTIBODY AND USE THEREOF
- Publication number 20220177590
- Publication date Jun 9, 2022
- Remegen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION
- Publication number 20220133633
- Publication date May 5, 2022
- Remegen Co., Ltd.
- Qiaoyu Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LINKER FOR ANTIBODY-DRUG CONJUGATES AND ITS USE
- Publication number 20220072137
- Publication date Mar 10, 2022
- RemeGen Co., Ltd.
- Changjiang Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TACI-FC FUSION PROTEINS AND USES THEREOF
- Publication number 20220002381
- Publication date Jan 6, 2022
- REMEGEN CO., LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANGIOGENESIS INHIBITOR AND USE THEREOF
- Publication number 20210324039
- Publication date Oct 21, 2021
- REMEGEN CO., LTD.
- Jing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FOR HER2 CONCOMITANT DIAGNOSIS IMMUNOHISTOCHEMICAL DETECTI...
- Publication number 20210238305
- Publication date Aug 5, 2021
- REMEGEN CO., LTD.
- Zhanjiao YU
- G01 - MEASURING TESTING

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
79319682 - HIBODY
- Serial number 79319682
- Filing date Apr 7, 2021
- RemeGen Co., Ltd.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79312573 - R REMEGEN
- Serial number 79312573
- Registration number 6908910
- Filing date Apr 7, 2021
- RemeGen Co., Ltd.
- 5 - Pharmaceutical and veterinary preparations

REMEGEN, LTD

Organization

Patents Grantslast 30 patents

Bifunctional angiogenesis inhibitor and use thereof

Patents Applicationslast 30 patents

USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-...

USE OF ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH IMMUNE CHECKPOIN...

METHOD FOR DETECTING TCEP CONTENT IN ADC BY LC-MS/MS

PHARMACEUTICAL COMBINATION AND USE THEREOF

METHOD FOR DETECTING DTPA CONTENT IN ADC BY LC-MS/MS

ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF

USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECI...

PREPARATION AND PURIFICATION METHOD OF ANTIBODY DRUG CONJUGATE INTE...

PREPARATION AND PURIFICATION PROCESS OF MONOMETHYL AURISTAIN E COMP...

METHOD FOR TREATING SJOGREN'S SYNDROME USING TACI-FC FUSION PROTEIN

METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN

ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF

BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF

ANTI PD-L1 ANTIBODY AND USE THEREOF

PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION

LINKER FOR ANTIBODY-DRUG CONJUGATES AND ITS USE

TACI-FC FUSION PROTEINS AND USES THEREOF

BIFUNCTIONAL ANGIOGENESIS INHIBITOR AND USE THEREOF

ANTIBODY FOR HER2 CONCOMITANT DIAGNOSIS IMMUNOHISTOCHEMICAL DETECTI...

Trademarklast 30 trademarks

79319682 - HIBODY

79312573 - R REMEGEN